Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Mirta Tomie Ito"'
Autor:
Sueli Matilde da Silva Costa, Mirta Tomie Ito, Pedro Rodrigues Sousa da Cruz, Bruno Batista De Souza, Vinicius Mandolesi Rios, Victor de Haidar e Bertozzo, Ana Carolina Lima Camargo, Marina Gonçalves Monteiro Viturino, Carolina Lanaro, Dulcinéia Martins de Albuquerque, Amanda Morato do Canto, Sara Teresinha Olalla Saad, Stephanie Ospina-Prieto, Margareth Castro Ozelo, Fernando Ferreira Costa, Mônica Barbosa de Melo
Publikováno v:
Experimental Biology and Medicine, Vol 249 (2024)
HbSC disease, a less severe form of sickle cell disease, affects the retina more frequently and patients have higher rates of proliferative retinopathy that can progress to vision loss. This study aimed to identify differences in the expression of en
Externí odkaz:
https://doaj.org/article/fa1706a357894d4bbcbdf5ba1859ce6d
Autor:
Gislene Pereira Gil, Galina Ananina, Mariana Maschietto, Sheila Coelho Soares Lima, Sueli Matilde da Silva Costa, Leticia de Carvalho Baptista, Mirta Tomie Ito, Fernando Ferreira Costa, Maria Laura Costa, Mônica Barbosa de Melo
Publikováno v:
PLoS ONE, Vol 17, Iss 9 (2022)
Pregnancy in Sickle Cell Disease (SCD) women is associated to increased risk of clinical and obstetrical complications. Placentas from SCD pregnancies can present increased abnormal findings, which may lead to placental insufficiency, favoring advers
Externí odkaz:
https://doaj.org/article/cd3b2454943d457f912782ddf97e0283
Autor:
Victor de Haidar e Bertozzo, Sueli Matilde da Silva Costa, Mirta Tomie Ito, Pedro Rodrigues Sousa da Cruz, Bruno Batista Souza, Vinicius Mandolesi Rios, Marina Gonçalves Monteiro Viturino, Júlia Nicoliello Pereira de Castro, Thiago Adalton Rosa Rodrigues, Carolina Lanaro, Dulcinéia Martins de Albuquerque, Roberta Casagrande Saez, Sara Teresinha Olalla Saad, Margareth Castro Ozelo, Fernando Ferreira Costa, Mônica Barbosa de Melo
Publikováno v:
Experimental Biology and Medicine. :153537022311579
Among sickle cell anemia (SCA) complications, proliferative sickle cell retinopathy (PSCR) is one of the most important, being responsible for visual impairment in 10–20% of affected eyes. The aim of this study was to identify differentially expres
Autor:
Fernando Ferreira Costa, Aderson S Araujo, Sara Teresinha Olalla Saad, Igor de Farias Domingos, Mônica Barbosa de Melo, Iscia Lopes-Cendes, Diego Arruda Falcão, Mirta Tomie Ito, Bruno Batista de Souza, Marcos André Cavalcanti Bezerra, Murilo Guimarães Borges, Sueli Matilde da Silva-Costa, Galina Ananina, Gabriela Queila de Carvalho-Siqueira, Marilda Souza Goncalves, Antonio R. Lucena-Araujo
Publikováno v:
Experimental Biology and Medicine. 244:932-939
Although sickle cell anemia results from homozygosity for a single mutation at position 7 of the β-globin chain, the clinical aspects of this condition are very heterogeneous. Complications include leg ulcers, which have a negative impact on patient
Autor:
Sara T.O. Saad, Fernando Ferreira Costa, Fernando Cendes, Mirta Tomie Ito, Margareth C. Ozelo, Roberta Casagrande Saez, Letícia C. Baptista, Mônica Barbosa de Melo, Stephanie Ospina-Prieto, Sueli Matilde da Silva Costa, Vinicius Mandolesi Rios, Dulcineia M. Albuquerque, Gabriela Queila de Carvalho-Siqueira, Karla Priscila Vieira
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background The clinical aspects of sickle cell anemia ( SCA ) are heterogeneous, and different patients may present significantly different clinical evolutions. Almost all organs can be affected, particularly the central nervous system. Transient isc
Autor:
Bruno Batista de Souza, Sueli Matilde da Silva Costa, Vinicius Mandolesi Rios, Fernando Ferreira Costa, Mirta Tomie Ito, Stephanie Ospina Pietro, Pedro Rodrigues Souza Cruz, Marina Gonçalves Monteiro Viturino, Margareth C. Ozelo, Letícia de Carvalho Bapista, Mônica Barbosa de Melo
Publikováno v:
Blood. 132:2368-2368
Retinopathy is one of the major clinical manifestations of sickle cell disease. Its clinical aspects vary depending on the presence or absence of vaso-proliferation, classifying this complication as non-proliferative and proliferative sickle cell ret